Iovance Biotherapeutics (NASDAQ: IOVA) aims to be the global leader in innovating, developing and delivering tumor infiltrating lymphocyte (TIL) therapies for patients with cancer. We are pioneering a transformational approach to cure cancer by harnessing the human immune system’s ability to recogni...See more
Headquarters:
United States of America
Company Type:
MNC / Large Enterprise
Company size:
501-1,000 Employees
Year Founded:
2007 (19 years)
Address:
825 INDUSTRIAL RD; SUITE 400; SAN CARLOS, CALIFORNIA 94070, US
HIGH
spending power